BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23610086)

  • 1. Reactive metabolite trapping studies on imidazo- and 2-methylimidazo[2,1-b]thiazole-based inverse agonists of the ghrelin receptor.
    Kalgutkar AS; Ryder TF; Walker GS; Orr ST; Cabral S; Goosen TC; Lapham K; Eng H
    Drug Metab Dispos; 2013 Jul; 41(7):1375-88. PubMed ID: 23610086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
    Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
    Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening.
    Yu J; Folmer JJ; Hoesch V; Doherty J; Campbell JB; Burdette D
    Drug Metab Dispos; 2011 Feb; 39(2):302-11. PubMed ID: 21045198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of PF-6870961, a major hydroxy metabolite of the novel ghrelin receptor inverse agonist PF-5190457.
    Sulima A; Akhlaghi F; Leggio L; Rice KC
    Bioorg Med Chem; 2021 Nov; 50():116465. PubMed ID: 34662828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
    Adusumalli S; Jamwal R; Obach RS; Ryder TF; Leggio L; Akhlaghi F
    Drug Metab Dispos; 2019 Aug; 47(8):874-882. PubMed ID: 31182423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam.
    Obach RS; Kalgutkar AS; Ryder TF; Walker GS
    Chem Res Toxicol; 2008 Sep; 21(9):1890-9. PubMed ID: 18707140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of substituted thiophenes including α-chlorothiophene-containing compounds in human liver microsomes.
    Chen W; Caceres-Cortes J; Zhang H; Zhang D; Humphreys WG; Gan J
    Chem Res Toxicol; 2011 May; 24(5):663-9. PubMed ID: 21417487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bioactivation mechanism of reactive metabolite formation from phenyl methyl-isoxazoles.
    Bylund J; Macsari I; Besidski Y; Olofsson S; Petersson C; Arvidsson PI; Bueters T
    Drug Metab Dispos; 2012 Nov; 40(11):2185-91. PubMed ID: 22908203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic electrophilicity of a 4-substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine derivative: structural characterization of glutathione conjugates in vitro.
    Kalgutkar AS; Mascitti V; Sharma R; Walker GW; Ryder T; McDonald TS; Chen Y; Preville C; Basak A; McClure KF; Kohrt JT; Robinson RP; Munchhof MJ; Cornelius P
    Chem Res Toxicol; 2011 Feb; 24(2):269-78. PubMed ID: 21288051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
    Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
    Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro microsomal metabolic studies on a selective mGluR5 antagonist MTEP: characterization of in vitro metabolites and identification of a novel thiazole ring opening aldehyde metabolite.
    Yang X; Chen W
    Xenobiotica; 2005 Aug; 35(8):797-809. PubMed ID: 16278192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of N-thiazol-2-yl benzamide as glucokinase activators: Impacts of glutathione trapping on covalent binding.
    Iino T; Hashimoto N; Hasegawa T; Chiba M; Eiki J; Nishimura T
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1619-22. PubMed ID: 20138764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry.
    Alvarez-Diez TM; Zheng J
    Drug Metab Dispos; 2004 Dec; 32(12):1345-50. PubMed ID: 15328249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.
    Tang C; Subramanian R; Kuo Y; Krymgold S; Lu P; Kuduk SD; Ng C; Feng DM; Elmore C; Soli E; Ho J; Bock MG; Baillie TA; Prueksaritanont T
    Chem Res Toxicol; 2005 Jun; 18(6):934-45. PubMed ID: 15962928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites.
    Tang W; Stearns RA; Bandiera SM; Zhang Y; Raab C; Braun MP; Dean DC; Pang J; Leung KH; Doss GA; Strauss JR; Kwei GY; Rushmore TH; Chiu SH; Baillie TA
    Drug Metab Dispos; 1999 Mar; 27(3):365-72. PubMed ID: 10064567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.